Skip to main navigation Skip to search Skip to main content

An open label, prospective, pharmacokinetic.pharmacodynamic and safety evaluation of intravenous oseltamivir (Tamiflu) in the treatments of infants 0<12 months of age with influenza infection protocol No. NP25138

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date01/7/10 → 08/15/13

Funding

  • Hoffmann Laroche Incorporated: $9,875.00